Title:
Catalyst Grant: SPOR Innovative Clinical Trials (iCT)
Agreement Value:
$191,811.00
Agreement Date:
Jan 1, 2024 - Dec 31, 2024
Description:
The specific objectives of this funding opportunity are to provide seed funding to:
• build relationships among researchers, PWLE, communities, health care professionals and others with a view to developing inclusive, equitable and culturally safe iCTs;
• mobilize research collaborations aimed at identifying priorities for iCT research; and,
• develop new and transformative methods relevant to iCTs, with the potential to generate high impact results.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Ottawa, Ontario, CA K1Y 4E9
Reference Number:
236-2023-2024-Q4-00390
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Fiedorowicz, Jess G
Research Organization:
Ottawa Hospital Research Institute|Institut de recherche de l’Hôpital d’Ottawa
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.